MannKind (Nasdaq:MNKD) is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
Recent Mentions on Fool.com
- MannKind Corporation Shares Were Rocked in March -- Here's Why
- 5 Big Losers if the Supreme Court Strikes Down Federal Obamacare Subsidies
- Investors' Love/Hate Relationship with MannKind Corp. Stock
- Did Researchers Just Unlock a Type 1 Diabetes Cure?
- Too Good to Be True? Proceed With Caution on These 2 Biotechs